Literature DB >> 26902993

Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays.

Jonathan Visentin1, Gwendaline Guidicelli2, Lionel Couzi3, Pierre Merville3, Jar-How Lee4, Carmelo Di Primo5, Jean-Luc Taupin6.   

Abstract

In flow beads assays, the interference of IgM for IgG anti-HLA antibodies detection is not precisely understood. Using the screening flow beads assay for class I HLA antibodies, we analyzed the binding of two IgG mAbs, the anti-class I HLA W6/32 and an anti-beta-2-microglobulin, in the presence of an anti-beta-2-microglobulin IgM mAb. In neat serum, the IgM mAb impaired the detection of both IgG. In EDTA-treated serum, the interference was stronger for the anti-beta-2-microglobulin IgG than for W6/32, in agreement with the finding in surface plasmon resonance that this IgM competed with the anti-beta-2-microglobulin IgG but not with W6/32. The IgM interference was higher in neat than in EDTA-treated serum for both IgG mAbs. The IgM interference was also analyzed with class II single antigen flow beads and sera from two kidney recipients containing IgG and IgM donor specific antibodies. Anti-HLA IgG detection was partially corrected by EDTA, and restored by IgM inactivation with DTT, confirming the results observed with the mAbs. Therefore, three mechanisms can explain the IgM interference for IgG anti-HLA antibodies in flow beads assays: direct competition for antigen, steric hindrance and complement activation.
Copyright © 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complement; HLA antibodies; IgM; Interference; Single antigen flow beads

Mesh:

Substances:

Year:  2016        PMID: 26902993     DOI: 10.1016/j.humimm.2016.02.008

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

1.  Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.

Authors:  Mepur H Ravindranath; Edward J Filippone; Grace Mahowald; Carly Callender; Adarsh Babu; Susan Saidman; Soldano Ferrone
Journal:  Immunol Res       Date:  2018-10       Impact factor: 2.829

2.  Evaluation of Antigen-Specific IgM and IgG Production during an In Vitro Peripheral Blood Mononuclear Cell Culture Assay.

Authors:  Yoshiko Matsuda; Ryoichi Imamura; Shiro Takahara
Journal:  Front Immunol       Date:  2017-07-10       Impact factor: 7.561

3.  Effect of the Anti-C1s Humanized Antibody TNT009 and Its Parental Mouse Variant TNT003 on HLA Antibody-Induced Complement Activation-A Preclinical In Vitro Study.

Authors:  M Wahrmann; J Mühlbacher; L Marinova; H Regele; N Huttary; F Eskandary; G Cohen; G F Fischer; G C Parry; J C Gilbert; S Panicker; G A Böhmig
Journal:  Am J Transplant       Date:  2017-03-31       Impact factor: 8.086

Review 4.  Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection.

Authors:  Yoshiko Matsuda; Takahisa Hiramitsu; Xiao-Kang Li; Takeshi Watanabe
Journal:  Pathogens       Date:  2020-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.